World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
41702
World Ranking
9930
National Ranking
140

Aleix Prat publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Aleix Prat sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,212 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Aleix Prat D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Aleix Prat sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Aleix Prat is affiliated with the University of Barcelona in Spain. Their research output spans several specialized fields within medicine and biochemistry, genetics, and molecular biology, with a particular focus on oncology.

The primary subfields of study in their work include:

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research
  • Genetics
  • Radiology, Nuclear Medicine and Imaging

Key research topics covered in their publications involve:

  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Breast Cancer Treatment Studies
  • Cancer Treatment and Pharmacology
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Monoclonal and Polyclonal Antibodies Research

Among Aleix Prat's recent papers are:

  • "Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer" (2022), published in New England Journal of Medicine
  • "Immune-related adverse events of checkpoint inhibitors" (2020), published in Nature Reviews Disease Primers
  • "Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021" (2021), published in Annals of Oncology
  • "Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer" (2021), published in npj Breast Cancer
  • "Frequency and spectrum of PIK3CA somatic mutations in breast cancer" (2020), published in Breast Cancer Research

Frequent co-authors who have collaborated extensively with Aleix Prat include:

  • Tomás Pascual
  • Fara Brasó-Maristany
  • Laia Paré
  • María Vidal
  • Patricia Galván

The main venues for publishing Aleix Prat's work encompass:

  • Cancer Research
  • Annals of Oncology
  • UNC Libraries
  • Journal of Clinical Oncology
  • ESMO Open

Best Publications

  • Comprehensive molecular portraits of human breast tumours

    Daniel C. Koboldt;Robert S. Fulton;Michael D. McLellan;Heather Schmidt

  • Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

    Aleix Prat;Joel S Parker;Olga Karginova;Cheng Fan

  • Deconstructing the molecular portraits of breast cancer.

    Aleix Prat;Charles M. Perou

  • Immune-related adverse events of checkpoint inhibitors.

    Manuel Ramos-Casals;Julie R. Brahmer;Margaret K. Callahan;Margaret K. Callahan;Alejandra Flores-Chávez

  • Clinical implications of the intrinsic molecular subtypes of breast cancer.

    Aleix Prat;Aleix Prat;Estela Pineda;Barbara Adamo;Barbara Adamo;Patricia Galván

  • Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts.

    Shunqiang Li;Dong Shen;Jieya Shao;Robert Crowder

  • Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

    Aleix Prat;Maggie Chon U. Cheang;Miguel Martín;Joel S. Parker

  • Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer

    Aleix Prat;Barbara Adamo;Maggie C.U. Cheang;Carey K. Anders

  • Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031

    Matthew J. Ellis;Vera J. Suman;Jeremy Hoog;Li Lin

  • PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition

    Yasir H. Ibrahim;Celina García-García;Violeta Serra;Lei He

  • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.

    H J Burstein;G Curigliano;B Thürlimann;W P Weber

  • A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

    Xiaomei Zhang;Sofie Claerhout;Aleix Prat;Lacey E. Dobrolecki

  • 進行性乳癌のためのESO-ESMO国際コンセンサスガイドライン第四版(ABC 4)

    F Cardoso;E Senkus;A Costa;E Papadopoulos

  • Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer.

    Francesco Schettini;Francesco Schettini;Nuria Chic;Nuria Chic;Fara Brasó-Maristany;Fara Brasó-Maristany;Laia Paré

  • USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma

    Pieter J A Eichhorn;Laura Rodón;Alba Gonzàlez-Juncà;Annette Dirac

  • PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer

    Ana Bosch;Zhiqiang Li;Anna Bergamaschi;Haley Ellis

  • PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers

    Roy R L Bastien;Álvaro Rodríguez-Lescure;Mark T W Ebbert;Aleix Prat;Aleix Prat

  • Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma

    Aleix Prat;Alejandro Navarro;Laia Paré;Noemí Reguart

  • Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors

    R. Dienstmann;J. Rodon;A. Prat;J. Perez-Garcia

  • Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients

    Maurizio Scaltriti;Pieter J. Eichhorn;Javier Cortés;Ludmila Prudkin

Frequent Co-Authors

Charles M. Perou
Charles M. Perou University of North Carolina at Chapel Hill
Javier Cortes
Javier Cortes Vall d'Hebron Hospital Universitari
Paolo Nuciforo
Paolo Nuciforo Vall d´Hebron Institute of Oncology
Joel S. Parker
Joel S. Parker University of North Carolina at Chapel Hill
José Baselga
José Baselga Memorial Sloan Kettering Cancer Center
Lisa A. Carey
Lisa A. Carey University of North Carolina at Chapel Hill
Maggie C.U. Cheang
Maggie C.U. Cheang Institute of Cancer Research
Josep Tabernero
Josep Tabernero Vall d´Hebron Institute of Oncology
Matthew J. Ellis
Matthew J. Ellis Baylor College of Medicine
Olufunmilayo I. Olopade
Olufunmilayo I. Olopade University of Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but considering alternatives to a traditional US medical degree, online programs offer flexible and accelerated options. Aspiring nurses or nurse practitioners can choose from pathways tailored to different experience levels and goals.

If you already hold a nursing license and want to advance quickly, consider the shortest dnp programs online. These Doctor of Nursing Practice (DNP) programs are designed to help working professionals reach the highest level of nursing practice in less time.

Those looking for an even faster route to a clinical doctorate can explore a 1 year dnp program online, which offers rapid progression for qualified nurses.

For individuals new to healthcare, an lpn program provides a quick way to enter the workforce as a Licensed Practical Nurse. LPN programs can often be completed online and lead to jobs in various healthcare settings.

Those aiming to specialize in mental health can explore the shortest pmhnp program to become a Psychiatric Mental Health Nurse Practitioner. These accelerated degrees prepare graduates for high-demand careers addressing mental wellness.

Best Scientists Citing Aleix Prat

Trending Scientists

Recently Published Articles